ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Trimethylamine N-Oxide Combined with Phenylacetylglutamine as Potential Biomarkers for Diabetic Kidney Disease.
Guiling Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.